The announcement of TerrAscend's intention to raise $15 million through private placements may have a neutral impact on the company's stock price in the short term. The funds will be used for the company's proposed TSX listing, Maryland dispensary acquisitions, and general corporate purposes, which may be seen as positive developments for the company. However, the issuance of new shares and debentures may dilute existing shareholders' ownership, which could have a negative impact on the stock price.